SAVE THE DATE: Scalable AAV production webinar
Adeno-associated virus (AAV) is rapidly becoming the go-to biological delivery method for the latest gene therapy breakthroughs. Already part of several high-profile drug approvals in both the USA and Europe, AAV is also used in over 100 clinical trials to-date. Such intensified interest in AAV therapies marks the need for effective workflow solutions to scale-up high titer viral production methods.
In this webinar, our scientists discuss how to optimize, scale, and qualify the manufacturing process for AAV production under tight timelines.
As a webinar attendee, you will learn about:
- Enabling scalable, high-titer AAV production in single use bioreactors
- How to optimize recovery and purity in downstream processing
- Robust and efficient AAV production workflows
For Asia-Pacific viewers, participate in the live Q&A session to address any questions you may have on AAV production, purification, and process-related matters!
Can‘t make the live event? Register anyway, and we‘ll send you a link to the recording.
Share this webinar with a colleague »